I serve as the Associate Director of Scientific Research at CellTrans, Incorporated. In my current role, I manage and execute rodent and non-human primate islet transplantation studies to restore normoglycemia in diabetic subjects, with a particular focus on biomaterials and encapsulation. Our organization collaborates with academic and industry partners to investigate novel bioengineered platforms to advance islet transplantation from bench to bedside. Our current project portfolio also includes assessment of alternative sources of islets in vivo. Our research program is supported by funding from the Juvenile Diabetes Research Foundation, Helmsley Foundation, and industry clients.